These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8947911)

  • 41. Autologous Platelet-Rich Plasma for the Treatment of Pattern Hair Loss.
    Singh B; Goldberg LJ
    Am J Clin Dermatol; 2016 Aug; 17(4):359-67. PubMed ID: 27234711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.
    Trüeb RM; Dias MFRG
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):68-87. PubMed ID: 28717940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microneedling for the treatment of hair loss?
    Fertig RM; Gamret AC; Cervantes J; Tosti A
    J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):564-569. PubMed ID: 29194786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of finasteride polymer microspheres for systemic application in androgenic alopecia.
    Kim JH; Na J; Bak DH; Lee BC; Lee E; Choi MJ; Ryu CH; Lee S; Mun SK; Park BC; Kim BJ; Lee HS
    Int J Mol Med; 2019 Jun; 43(6):2409-2419. PubMed ID: 30942390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia?
    Harries MJ; Meyer KC; Chaudhry IH; Griffiths CE; Paus R
    Clin Exp Dermatol; 2010 Aug; 35(6):637-44. PubMed ID: 19886964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-6 cytokine family member oncostatin M is a hair-follicle-expressed factor with hair growth inhibitory properties.
    Yu M; Kissling S; Freyschmidt-Paul P; Hoffmann R; Shapiro J; McElwee KJ
    Exp Dermatol; 2008 Jan; 17(1):12-9. PubMed ID: 17979974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness.
    Hamada K; Randall VA
    Br J Dermatol; 2006 Apr; 154(4):609-18. PubMed ID: 16536801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DERMAL ADIPOSE TISSUE IN HAIR FOLLICLE CYCLING: POSSIBLE APPLICATIONS IN ALOPECIA?
    Wollina U; Abdel NM; Kruglikov I
    Georgian Med News; 2017 Apr; (265):41-45. PubMed ID: 28574382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of sinapic acid on hair growth promoting in human hair follicle dermal papilla cells via Akt activation.
    Woo H; Lee S; Kim S; Park D; Jung E
    Arch Dermatol Res; 2017 Jul; 309(5):381-388. PubMed ID: 28321536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata.
    Philpott MP; Sanders DA; Bowen J; Kealey T
    Br J Dermatol; 1996 Dec; 135(6):942-8. PubMed ID: 8977716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Techniques for the discovery and evaluation of drugs against alopecia.
    Semalty A; Semalty M; Joshi GP; Rawat MS
    Expert Opin Drug Discov; 2011 Mar; 6(3):309-21. PubMed ID: 22647205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic and molecular aspects of androgenetic alopecia.
    Martinez-Jacobo L; Villarreal-Villarreal CD; Ortiz-López R; Ocampo-Candiani J; Rojas-Martínez A
    Indian J Dermatol Venereol Leprol; 2018; 84(3):263-268. PubMed ID: 29595184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic analysis of a novel antioxidant multi-target iron chelator, M30 protecting against chemotherapy-induced alopecia in mice.
    Lim YC; Kim H; Lim SM; Kim JS
    BMC Cancer; 2019 Feb; 19(1):149. PubMed ID: 30760223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy-induced alopecia.
    Trüeb RM
    Semin Cutan Med Surg; 2009 Mar; 28(1):11-4. PubMed ID: 19341937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alopecia--a challenge for dermatologists.
    Brănişteanu DE; Voicu CM; Brănişteanu DC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):11-8. PubMed ID: 24741769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular genetics of alopecias.
    Ramot Y; Zlotogorski A
    Curr Probl Dermatol; 2015; 47():87-96. PubMed ID: 26370647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging treatments in alopecia.
    Falto-Aizpurua L; Choudhary S; Tosti A
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):545-56. PubMed ID: 25330928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gsdma3 is required for hair follicle differentiation in mice.
    Li J; Zhou Y; Yang T; Wang N; Lian X; Yang L
    Biochem Biophys Res Commun; 2010 Dec; 403(1):18-23. PubMed ID: 20977888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delineating immune-mediated mechanisms underlying hair follicle destruction in the mouse mutant defolliculated.
    Ruge F; Glavini A; Gallimore AM; Richards HE; Thomas CP; O'Donnell VB; Philpott MP; Porter RM
    J Invest Dermatol; 2011 Mar; 131(3):572-9. PubMed ID: 21160494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemoprevention of doxorubicin-induced alopecia in mice by dietary administration of L-cystine and vitamin B6.
    D'Agostini F; Fiallo P; Ghio M; De Flora S
    Arch Dermatol Res; 2013 Jan; 305(1):25-34. PubMed ID: 22699427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.